Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: A clinicopathological study

Neuro-Oncology

Volumn 14, Issue 2, 2012, Pages 230-241

  You, Gan ^a   Sha, Zhi Yi ^b   Yan, Wei ^a   Zhang, Wei ^a   Wang, Yong Zhi ^a   Li, Shao Wu ^a   Sang, Lin ^c   Wang, Zi ^d   Li, Gui Lin ^e   Li, Shou Wei ^e   Song, Yi Jun ^f   Kang, Chun Sheng ^f   Jiang, Tao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Huaishuling Branch of Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine   (China)

^d Beijing Electric Power Company   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

calcification; extent of resection; Ki67; low grade glioma; seizure

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER SURGERY; CLINICAL FEATURE; FEMALE; FOLLOW UP; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; SEIZURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHINA; COHORT STUDIES; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859520953     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nor205     Document Type: Article

References (54)

1. Chang EF, Potts MB, Keles GE, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008;108:227-235. (Pubitemid 351213284)
2. Leighton C, Fisher B, Bauman G, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol. 1997;15:1294-1301. (Pubitemid 27167360)
3. Schaller B, Rüegg SJ. Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia. 2003;44:1223-1232. (Pubitemid 37100049)
4. Danfors T, Ribom D, Berntsson SG, Smits A. Epileptic seizures and survival in early disease of grade 2 gliomas. Eur J Neurol. 2009;16:823-831.
5. Hildebrand J, Lecaille C, Perennes J, Delattre JY. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology. 2005;65:212-215. (Pubitemid 41022363)
6. Lynam LM, Lyons MK, Drazkowski JF, et al. Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg. 2007;109:634-638. (Pubitemid 47016762)
7. Lee JW, Wen PY, Hurwitz S, et al. Morphological characteristics of brain tumors causing seizures. Arch Neurol. 2010;67:336-342.
8. You G, Huang L, Yang P, et al. Clinical and molecular genetic factors affecting post-operative seizure control of 183 Chinese adult patients with low-grade gliomas. Eur J Neurol. 2011. doi:10.1111/j.1468-1331.2011.03509.x.
9. Engel J, Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42:796-803. (Pubitemid 32605946)
10. Korshunov A, Golanov A, Sycheva R. Immunohistochemical markers for prognosis of cerebral glioblastomas. J Neurooncol. 2002;58:217-236. (Pubitemid 34830634)
11. Brell M, Tortosa A, Verger E, et al. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin Cancer Res. 2005;11:5167-5174. (Pubitemid 41003702)
12. Kujas M, Lejeune J, Benouaich-Amiel A, et al. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol. 2005;58:322-326. (Pubitemid 41098891)
13. Lote K, Stenwig AE, Skullerud K, Hirschberg H. Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer. 1998;34:98-102. (Pubitemid 28123388)
14. Villemure JG, de Tribolet N. Epilepsy in patients with central nervous system tumors. Curr Opin Neurol. 1996;9:424-428. (Pubitemid 27042602)
15. Pace A, Bove L, Innocenti P, et al. Epilepsy and gliomas: incidence and treatment in 119 patients. J Exp Clin Cancer Res. 1998;17:479-482. (Pubitemid 29083423)
16. LaRoche SM, Helmers SL. Epilepsy in the elderly. Neurologist. 2003;9:241-249. (Pubitemid 37193789)
17. DeAngelis LM. Brain tumors. N Engl J Med. 2001;344:114-123.
18. Chaichana KL, Parker SL, Olivi A, Quiñ ones-Hinojosa A. Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. J Neurosurg. 2009;111:282-292.
19. HuangL,YouG, JiangT, LiGL, LiSW,WangZC.Correlationbetweentumorrelated seizures and molecular genetic profile in 103 Chinese patients with low-grade gliomas: a preliminary study. J Neurol Sci. 2010;302:63-67.
20. Jacoby A, Wang W, Vu TD, et al. Meanings of epilepsy in its socio cultural context and implications for stigma: findings from ethnographic studies in local communities in China and Vietnam. Epilepsy Behav. 2008;12:286-297.
21. Luyken C, Blümcke I, Fimmers R, et al. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia. 2003;44:822-830. (Pubitemid 36754008)
22. Rosati A, Tomassini A, Pollo B, et al. Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neurooncol. 2009;93:395-400.
23. Zaatreh MM, Firlik KS, Spencer DD, Spencer SS. Temporal lobe tumoral epilepsy: characteristics and predictors of surgical outcome. Neurology. 2003;61:636-641. (Pubitemid 37082600)
24. Pallud J, Capelle L, Taillandier L, et al. Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro Onco. 2009;11:176-182.
25. Schiff D, Brown PD, Giannini C. Outcome in adult low-grade glioma: the impact of prognostic factors and treatment. Neurology. 2007;69:1366-1373. (Pubitemid 47482451)
26. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002;20:2076-2084. (Pubitemid 34408798)
27. El-Hateer H, Souhami L, Roberge D, et al. Low-grade oligodendroglioma: an indolent but incurable disease?. J Neurosurg. 2009;111:265-271.
28. Khan RB, Hunt DL, Thompson SJ. Gabapentin to control seizures in children undergoing cancer treatment. J Child Neurol. 2004;19:97-101. (Pubitemid 38425760)
29. Khan RB, Boop FA, Onar A, Sanford RA. Seizures in children with lowgrade tumors: outcome after tumor resection and risk factors for uncontrolled seizures. J Neurosurg. 2006;104:377-382. (Pubitemid 44954810)
30. Restrepo BI, Alvarez JI, Castano JA, et al. Brain granulomas in neurocysticercosis patients is associated with a Th1 and Th2 profile. Infect Immun. 2001;69:4554-4560. (Pubitemid 32574457)
31. Singh G, Sachdev MS, Tirath A, Gupta AK, Avasthi G. Focal corticalsubcortical calcifications (FCSCs) and epilepsy in the Indian subcontinent. Epilepsia. 2000;41:718-726. (Pubitemid 30390425)
32. Agarwal A, Raghav S, Husain M, Kumar R, Gupta RK. Epilepsy with focal cerebral calcification: role of magnetization transfer MR imaging. Neurol India. 2004;52:197-199. (Pubitemid 39136950)
33. Murthy JM, Subba Reddy YV. Prognosis of epilepsy associated with single CT enhancing lesion: a long-term follow-up study. J Neurol Sci. 1998;159:151-155. (Pubitemid 28384521)
34. Schaller B. Influences of brain tumor-associated pH changes and hypoxia on epileptogenesis. Acta Neurol Scand. 2005;111:75-83. (Pubitemid 40175328)
35. WolfHK,RoosD, Blumcke I, Pietsch T,WiestlerOD.Perilesional neurochemical changes in focal epilepsies. Acta Neuropathol. 1996;91:376-384. (Pubitemid 26088973)
36. Bordey A, Sontheimer H. Electrophysiological properties of human astrocytic tumor cells In situ: enigma of spiking glial cells. J Neurophysiol. 1998;79:2782-2793. (Pubitemid 28261657)
37. Bordey A, Sontheimer H. Properties of human glial cells associated with epileptic seizure foci. Epilepsy Res. 1998;32:286-303. (Pubitemid 28419497)
38. Ye ZC, Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res. 1999;59:4383-4391. (Pubitemid 29418758)
39. Simon M, Neuloh G, von Lehe M, Meyer B, Schramm J. Insular gliomas: the case for surgical management. J Neurosurg. 2009;110:685-695.
40. Duffau H, Capelle L, Lopes M, Bitar A, Sichez JP, van Effenterre R. Medically intractable epilepsy from insular low-grade gliomas: improvement after an extended lesionectomy. Acta Neurochir (Wien). 2002;144:563-572.
41. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109:93-108. (Pubitemid 40287792)
42. Wiencke JK, Aldape K, McMillan A, et al. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNAalkyltransferase. Cancer Epidemiol Biomarkers Prev. 2005;14:1774-1783. (Pubitemid 40995094)
43. Sá nchez-Carpintero Abad R, Sanmartí Vilaplana FX, Serratosa Ferná ndez JM. Genetic causes of epilepsy. Neurologist. 2007;13:S47-51.
44. Rees MI. The genetics of epilepsy: the past, the present and future. Seizure. 2010;19:680-683.
45. Pitkänen A, Lukasiuk K. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav. 2009;14:16-25.
46. Prayson RA. Ki67 immunoreactivity in type II malformations of cortical development. Appl Immunohistochem Mol Morphol. 2008;16:357-361.
47. Kee N, Sivalingam S, Boonstra R, Wojtowicz JM. The utility of Ki67 and BrdU as proliferative markers of adult neurogenesis. J Neurosci Methods. 2002;115:97-105. (Pubitemid 34202283)
48. Rush SZ, Abel TW, Valadez JG, Pearson M, Cooper MK. Activation of the Hedgehog pathway in pilocytic astrocytomas. Neuro Onco. 2010;12:790-798.
49. Herman ST. Epilepsy after brain insult: targeting epileptogenesis. Neurology. 2002;59:S21-S26. (Pubitemid 35285971)
50. Wolf HK, Müller MB, Spanle M, Zentner J, Schramm J, Wiestler OD. Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases. Acta Neuropathol. 1994;88:166-173. (Pubitemid 24233248)
51. Tantbirojn P, Sanpavat A, Bunyaratavei K, Desudchit T, Shuangshoti S. Desmoplastic infantile ganglioglioma with high proliferation index: report of a case. J Med Assoc Thai. 2005;88:1962-1965. (Pubitemid 43275738)
52. Krex D, Klink B, Hartmann C, et al. Long-term survival with glioblastoma multiforme. Brain. 2007;130:2596-2606. (Pubitemid 47511715)
53. Dinapoli L, Maschio M, Jandolo B, et al. Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study. Neuro Sci. 2009;30:353-359.
54. van Breemen MSM, Rijsman RM, Taphoorn MJB, Walchenbach R, Zwinkels H, Vecht CJ. Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol. 2009;256:1519-1526.